Body Composition Assessment in Spinal Cord Injury

Sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center (U.S. Fed)
Overall Status
Unknown status
CT.gov ID
NCT00957762
Collaborator
(none)
170
1
38
4.5

Study Details

Study Description

Brief Summary

The purpose of this research is to evaluate different methods of measuring body composition (amount of fat, muscle, bone, and water in your body) and to determine relationships between body composition and other medical problems associated with spinal cord injury (SCI).

Condition or Disease Intervention/Treatment Phase
  • Other: Body composition

Detailed Description

A preliminary investigation in our laboratory has demonstrated the advantage of using 4-compartment modeling to assess body composition in SCI adults. In comparing body composition analyses techniques in 20 individuals with SCI, we found Total Error to be 8.0% with Dual X-ray Absorptiometry, 8.4% with hydrodensitometry, 11.5% with bioelectrical impedance analysis, and 21.8% with standard skinfold equations when compared to 4-compartment modeling, the currently accepted gold standard for body composition assessment. To date there is no gold standard for the determination of body composition in SCI individuals.

Study Design

Study Type:
Observational
Anticipated Enrollment :
170 participants
Time Perspective:
Prospective
Official Title:
Body Composition Assessment in Spinal Cord Injury
Study Start Date :
Aug 1, 2009
Anticipated Primary Completion Date :
Sep 1, 2012
Anticipated Study Completion Date :
Oct 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Body Composition

120 subjects will help create the regression models. The remaining 50 subjects will be recruited to determine if the equations work for the population.

Other: Body composition
Day 1 testing will incorporate underwater weighing, Bod Pod, DXA, BIA and anthropometrics. Day 2 will include RMR, MRI, and testing at GCRC
Other Names:
  • Spinal Cord Injury
  • Percentage body fat
  • Outcome Measures

    Primary Outcome Measures

    1. To compare different methods of body composition analyses with the gold standard 4-compartment monitoring to determine accuracy and validity of those alternative, but less labor-intensive techniques. [3 years]

    Secondary Outcome Measures

    1. To assess the relationship between % body fat, visceral fat, and markers of the metabolic syndrome, including Plasminogen Activator Inhibitor-1 (PAI-1), Thrombin-Activatable Fibrinolysis Inhibitor (TAFI), and high-sensitivity C-Reactive Protein (hsCRP) [3 years]

    2. To develop body composition regression equations that can be easily utilized in a clinical setting to estimate risk for the metabolic syndrome in persons with SCI. [3 years]

    3. To cross-validate the derived regression equations against the gold standard 4-compartment model in an independent group of persons with SCI. [3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Criteria for participation will include men and women within the age range of 18-65 years old with C5-L2 Motor-Complete (ASIA A&B)

    • SCI of duration greater than 12 months to ensure a homogenous sample.

    Exclusion Criteria:
    • Persons with uncompensated hypothyroidism, and/or renal disease will be excluded from the study.

    • Additionally, individuals with uncontrolled autonomic dysreflexia, recent (within 3 months) deep vein thrombosis

    • Pressure ulcers > Grade II will be excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hunter Holmes McGuire Spinal Cord Injury Research Lab Richmond Virginia United States 23249

    Sponsors and Collaborators

    • Hunter Holmes Mcguire Veteran Affairs Medical Center

    Investigators

    • Principal Investigator: David R Gater, MD, PhD, Hunter Holmes McGuire VAMC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00957762
    Other Study ID Numbers:
    • B6232I
    • HM12090
    First Posted:
    Aug 12, 2009
    Last Update Posted:
    Aug 12, 2009
    Last Verified:
    Aug 1, 2009

    Study Results

    No Results Posted as of Aug 12, 2009